IL118142A - Pharmaceutical composition containing tiagabine hydrochloride together with antioxidants and its preparation - Google Patents

Pharmaceutical composition containing tiagabine hydrochloride together with antioxidants and its preparation

Info

Publication number
IL118142A
IL118142A IL11814296A IL11814296A IL118142A IL 118142 A IL118142 A IL 118142A IL 11814296 A IL11814296 A IL 11814296A IL 11814296 A IL11814296 A IL 11814296A IL 118142 A IL118142 A IL 118142A
Authority
IL
Israel
Prior art keywords
antioxidants
preparation
pharmaceutical composition
composition containing
tiagabine hydrochloride
Prior art date
Application number
IL11814296A
Other languages
English (en)
Other versions
IL118142A0 (en
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL118142A0 publication Critical patent/IL118142A0/xx
Publication of IL118142A publication Critical patent/IL118142A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IL11814296A 1995-05-05 1996-05-03 Pharmaceutical composition containing tiagabine hydrochloride together with antioxidants and its preparation IL118142A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK52395 1995-05-05

Publications (2)

Publication Number Publication Date
IL118142A0 IL118142A0 (en) 1996-09-12
IL118142A true IL118142A (en) 1999-11-30

Family

ID=8094516

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11814296A IL118142A (en) 1995-05-05 1996-05-03 Pharmaceutical composition containing tiagabine hydrochloride together with antioxidants and its preparation

Country Status (26)

Country Link
US (1) US5866590A (zh)
EP (1) EP0830132B1 (zh)
JP (1) JP3195360B2 (zh)
KR (1) KR100440354B1 (zh)
CN (1) CN1092959C (zh)
AR (1) AR003418A1 (zh)
AT (1) ATE211911T1 (zh)
AU (1) AU707508B2 (zh)
BR (1) BR9608120A (zh)
CA (1) CA2220019C (zh)
CZ (1) CZ292256B6 (zh)
DE (1) DE69618586T2 (zh)
DK (1) DK0830132T3 (zh)
EG (1) EG23781A (zh)
ES (1) ES2171669T3 (zh)
HU (1) HU223075B1 (zh)
IL (1) IL118142A (zh)
MX (1) MX9708394A (zh)
MY (1) MY115016A (zh)
NO (1) NO318599B1 (zh)
NZ (1) NZ307159A (zh)
PL (1) PL183678B1 (zh)
PT (1) PT830132E (zh)
UA (1) UA43402C2 (zh)
WO (1) WO1996034606A1 (zh)
ZA (1) ZA963478B (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
PT991409E (pt) * 1997-08-01 2002-06-28 Elan Corp Plc Composicoes farmaceuticas de libertacao controlada contendo tiagabina
IE970588A1 (en) 1997-08-01 2000-08-23 Elan Corp Plc Controlled release pharmaceutical compositions containing tiagabine
AU9432498A (en) * 1997-10-02 1999-04-27 H. Lundbeck A/S Granular preparations of 5-(2-ethyl- 2(h)-tetrazol- 5-yl)-1-methyl-1, 2,3,6-tetrahydropyridine
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
AU2002325404B2 (en) * 1998-01-22 2006-02-02 Abbott Laboratories Extended Release Tiagabine Formulations with Reduced Side-effects
ZA99407B (en) * 1998-01-22 1999-07-20 Abbott Lab Extended release tiagabine formulations with reduced side-effects.
WO2001091751A1 (en) * 2000-05-30 2001-12-06 Novo Nordisk A/S New pharmaceutical composition and the process for its preparation
EP1303273A1 (en) 2000-05-26 2003-04-23 Novo Nordisk A/S New pharmaceutical composition and the process for its preparation
WO2006067605A1 (en) * 2004-12-23 2006-06-29 Ranbaxy Laboratories Limited Stable pharmaceutical compositions of tiagabine and processes for their preparation
CN102125693A (zh) * 2011-01-25 2011-07-20 福建科瑞药业有限公司 一种盐酸噻加宾药物组合物及其制备方法
AU2013257707A1 (en) * 2012-05-08 2014-11-27 Cellixbio Private Limited Compositions and methods for the treatment of epilepsy
WO2017038612A1 (ja) * 2015-08-28 2017-03-09 日本化薬株式会社 ラパマイシン又はその誘導体を含有する医薬組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US501090A (en) * 1893-07-11 gennert
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
DK58291D0 (da) * 1991-04-02 1991-04-02 Novo Nordisk As Krystalinsk stof og dets fremstilling
WO1995005808A1 (en) * 1993-08-24 1995-03-02 Abbott Laboratories Oil-based tableting method
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies

Also Published As

Publication number Publication date
MX9708394A (es) 1998-02-28
AR003418A1 (es) 1998-08-05
BR9608120A (pt) 1999-02-09
DK0830132T3 (da) 2002-04-29
PL323138A1 (en) 1998-03-16
EP0830132B1 (en) 2002-01-16
CA2220019A1 (en) 1996-11-07
EP0830132A1 (en) 1998-03-25
CN1092959C (zh) 2002-10-23
MY115016A (en) 2003-03-31
DE69618586T2 (de) 2002-09-05
ATE211911T1 (de) 2002-02-15
ES2171669T3 (es) 2002-09-16
CZ292256B6 (cs) 2003-08-13
PL183678B1 (pl) 2002-06-28
IL118142A0 (en) 1996-09-12
NO975076L (no) 1997-11-04
WO1996034606A1 (en) 1996-11-07
NO318599B1 (no) 2005-04-18
JPH10505359A (ja) 1998-05-26
NZ307159A (en) 1998-10-28
ZA963478B (en) 1996-11-13
CA2220019C (en) 2007-12-11
EG23781A (en) 2007-08-13
HUP9802741A3 (en) 1999-04-28
HUP9802741A2 (hu) 1999-03-29
UA43402C2 (uk) 2001-12-17
NO975076D0 (no) 1997-11-04
CN1183721A (zh) 1998-06-03
AU5644196A (en) 1996-11-21
DE69618586D1 (de) 2002-02-21
HU223075B1 (hu) 2004-03-01
CZ338897A3 (cs) 1998-03-18
AU707508B2 (en) 1999-07-15
US5866590A (en) 1999-02-02
PT830132E (pt) 2002-07-31
JP3195360B2 (ja) 2001-08-06
KR100440354B1 (ko) 2004-09-18

Similar Documents

Publication Publication Date Title
IL114622A0 (en) Heteroaryl-oxazolidinones and pharmaceutical compositions containing them
IL116851A (en) 3-arylidene-2-oxindole derivatives and pharmaceutical compositions containing them
IL121236A0 (en) Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them
IL119995A0 (en) Pyrido-fused thienyl - and furanyl-oxazolidinones their preparation and pharmaceutical compositions containing them
HUP0000474A3 (en) Arylethenesulfonamide derivatives and drug composition containing the same
HUP9900424A2 (hu) Tiazolil-benzfurán-származékok és a vegyületeket tartalmazó gyógyászati készítmények
IL117554A0 (en) Imidazoquinazolines their preparation and pharmaceutical compositions containing them
IL117815A0 (en) Ascomycins their preparation and pharmaceutical compositions containing them
ZA967800B (en) Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them
IL118142A (en) Pharmaceutical composition containing tiagabine hydrochloride together with antioxidants and its preparation
HUP9602196A2 (en) Sulfonyl- and sulfinyl-benzoyl-guanidine derivatives and pharmaceutical compositions thereof
HUP0003189A2 (en) Pharmaceutical composition comprising fexofenadine and its derivatives
IL140742A0 (en) Raloxifene and pharmaceutical composition comprising the same
IL119371A0 (en) Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them
IL118672A0 (en) Benzisothiazolyl-substituted aminomethylchromans their preparation and pharmaceutical compositions containing them
HU9500386D0 (en) Benzodiazepine derivatives and pharmaceutical compositions containing them
IL118141A0 (en) Tetralines their preparation and pharmaceutical compositions containing them
IL115982A (en) Cyclolignan derivatives and pharmaceutical compositions containing them
HUP9802291A3 (en) Penicillaminamide derivatives and pharmaceutical compositions containing them
HUP9903619A3 (en) Pharmaceutical composition containing a 5ht2c antagonist and a d2 antagonist
IL113415A (en) Dihydrodibenziso-quinolinediones their preparation and pharmaceutical compositions containing them
HUP0000275A3 (en) Phenanethridinium derivatives and pharmaceutical compositions containing them
HUP9903375A3 (en) Synergistic pharmaceutical compositions containing olanzapine and analgetic drugs
IL114161A0 (en) Amido- quinoxalinediones pharmaceutical compositions containing them and their use
HUP9901968A3 (en) 2-thioxotetrahydropyrimidin-4-one derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees